LAS VEGAS SANDS ($LVS) posted quarterly earnings results on Wednesday, July 23rd. The company reported earnings of $0.79 per share, beating estimates of $0.53 by $0.26. The company also reported revenue of $3,175,000,000, beating estimates of $2,858,810,484 by $316,189,516.
You can see Quiver Quantitative's $LVS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LAS VEGAS SANDS Insider Trading Activity
LAS VEGAS SANDS insiders have traded $LVS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LVS stock by insiders over the last 6 months:
- MUKTESH PANT purchased 23,000 shares for an estimated $1,000,730
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LAS VEGAS SANDS Hedge Fund Activity
We have seen 313 institutional investors add shares of LAS VEGAS SANDS stock to their portfolio, and 327 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 31,592,047 shares (-53.7%) from their portfolio in Q1 2025, for an estimated $1,220,400,775
- FISHER ASSET MANAGEMENT, LLC removed 13,743,368 shares (-99.5%) from their portfolio in Q1 2025, for an estimated $530,906,305
- JANUS HENDERSON GROUP PLC removed 6,382,458 shares (-44.9%) from their portfolio in Q1 2025, for an estimated $246,554,352
- CITADEL ADVISORS LLC added 4,578,100 shares (+456.6%) to their portfolio in Q1 2025, for an estimated $176,852,003
- JANE STREET GROUP, LLC added 3,718,116 shares (+61.3%) to their portfolio in Q1 2025, for an estimated $143,630,821
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 3,204,897 shares (-34.2%) from their portfolio in Q1 2025, for an estimated $123,805,171
- VANGUARD GROUP INC added 2,267,307 shares (+5.8%) to their portfolio in Q1 2025, for an estimated $87,586,069
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LAS VEGAS SANDS Congressional Stock Trading
Members of Congress have traded $LVS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LVS stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LAS VEGAS SANDS Analyst Ratings
Wall Street analysts have issued reports on $LVS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Susquehanna issued a "Positive" rating on 07/21/2025
- Barclays issued a "Overweight" rating on 07/18/2025
- Macquarie issued a "Outperform" rating on 04/24/2025
- Stifel issued a "Buy" rating on 04/24/2025
- Citigroup issued a "Buy" rating on 01/30/2025
- Wells Fargo issued a "Overweight" rating on 01/30/2025
To track analyst ratings and price targets for LAS VEGAS SANDS, check out Quiver Quantitative's $LVS forecast page.
LAS VEGAS SANDS Price Targets
Multiple analysts have issued price targets for $LVS recently. We have seen 10 analysts offer price targets for $LVS in the last 6 months, with a median target of $54.5.
Here are some recent targets:
- Joseph Stauff from Susquehanna set a target price of $58.0 on 07/21/2025
- Brandt Montour from Barclays set a target price of $57.0 on 07/18/2025
- Stephen Grambling from Morgan Stanley set a target price of $47.0 on 07/11/2025
- Robin Farley from UBS set a target price of $48.0 on 07/08/2025
- Lizzie Dove from Goldman Sachs set a target price of $52.0 on 07/07/2025
- Daniel Politzer from JP Morgan set a target price of $47.0 on 06/23/2025
- Chad Beynon from Macquarie set a target price of $52.0 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.